Evidence map›Paper›PMID 34359923›Full record

ReviewCells2021

Multifunctionality of the Telomere-Capping Shelterin Complex Explained by Variations in Its Protein Composition.

Claire Ghilain, Eric Gilson, Marie-Josèphe Giraud-Panis

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Telomere-Related Gene Networks in the Ovary Shift Across Environmental Factors.Journal of experimental zoology. Part A, Ecological and integrative physiology · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Biomarkers of aging.Science China. Life sciences · 2023
    Review
  16. Article
  17. Heat-KilledInternational journal of molecular sciences · 2023
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Claire GhilainUniversité Côte d'Azur, CNRS, INSERM, IRCAN, 06000 Nice, France.
Eric GilsonUniversité Côte d'Azur, CNRS, INSERM, IRCAN, 06000 Nice, France.
Marie-Josèphe Giraud-PanisUniversité Côte d'Azur, CNRS, INSERM, IRCAN, 06000 Nice, France.
Inserm · FRInstitut de Recherche sur le Cancer et le Vieillissement de Nice · FRUniversité Côte d'Azur · FR

Funding

Agence Nationale de la Recherche TELOCHROMFondation ARC pour la Recherche sur le Cancer ProgrammeInstitut National de la Santé et de la Recherche Médicale AGEMED
6 · The paper itself

Abstract

Protecting telomere from the DNA damage response is essential to avoid the entry into cellular senescence and organismal aging. The progressive telomere DNA shortening in dividing somatic cells, programmed during development, leads to critically short telomeres that trigger replicative senescence and thereby contribute to aging. In several organisms, including mammals, telomeres are protected by a protein complex named Shelterin that counteract at various levels the DNA damage response at chromosome ends through the specific function of each of its subunits. The changes in Shelterin structure and function during development and aging is thus an intense area of research. Here, we review our knowledge on the existence of several Shelterin subcomplexes and the functional independence between them. This leads us to discuss the possibility that the multifunctionality of the Shelterin complex is determined by the formation of different subcomplexes whose composition may change during aging.

Indexed as

AnimalsDNADNA ReplicationHumansModels, MolecularProtein Structure, QuaternaryTelomereTelomere-Binding ProteinsDNATelomere-Binding ProteinsagingDNA damage responsesenescenceShelterintelomere

Identifiers

PMID34359923
PMCPMC8305809
OpenAlexW3179988722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.